Pancreatic cancer 363559 225355423 2008-07-13T07:02:10Z SmackBot 433328 Date the maintenance tags or general fixes {{Infobox_Disease| Name = Pancreatic cancer | Image = Illu pancrease.jpg | Caption = | DiseasesDB = 9510 | ICD10 = {{ICD10|C|25||c|15}} | ICD9 = {{ICD9|157}} | ICDO = | OMIM = 260350 | MedlinePlus = 000236 | eMedicineSubj = med | eMedicineTopic = 1712 | MeshID = D010190 | }} '''Pancreatic cancer''' is a [[cancer|malignant tumor]] of the [[pancreas]]. Each year about 37,680 individuals in the [[United States]] are diagnosed with this condition, and 34,290 die from the disease. In [[Europe]] more than 60,000 are diagnosed each year. Depending on the extent of the tumor at the time of diagnosis, the prognosis is generally regarded as poor, with <5% of those diagnosed still alive five years after diagnosis, and complete [[remission (medicine)|remission]] still extremely rare.<ref name=Ghaneh>{{cite journal |author=Ghaneh P, Costello E, Neoptolemos JP |title=Biology and management of pancreatic cancer |journal=Gut |volume=56 |issue=8 |pages=1134–52 |year=2007 |pmid=17625148 |doi=10.1136/gut.2006.103333}}</ref> About 95 percent{{Fact|date=July 2008}} of pancreatic tumors are [[adenocarcinoma]]s ({{ICDO|8140|3}}). The remaining 5 percent include other tumors of the exocrine pancreas (''e.g.,'' serous [[cystadenoma]]s), acinar cell cancers, and pancreatic [[neuroendocrine tumor]]s (such as [[insulinoma]]s, {{ICDO|8150|1}}, {{ICDO|8150|3}}). These tumors have a completely different diagnostic and therapeutic profile, and generally a more favorable prognosis.<ref name=Ghaneh/> ==Signs and symptoms== ===Presentation=== Early diagnosis of pancreatic cancer is difficult because the symptoms are so non-specific and varied. Common symptoms include [[abdominal pain|pain in the upper abdomen]] that typically radiates to the back and is relieved by leaning forward (seen in carcinoma of the body or tail of the pancreas), [[loss of appetite]], significant [[weight loss]] and painless [[jaundice]] related to [[bile duct]] obstruction (carcinoma of the head of the pancreas). All of these symptoms can have multiple other causes. Therefore, pancreatic cancer is often not diagnosed until it is advanced. [[Jaundice]] occurs when the tumor grows and obstructs the [[common bile duct]], which runs partially through the head of the pancreas. Tumors of the head of the pancreas (approximately 60% of cases) are more likely to cause jaundice by this mechanism. [[Trousseau's sign of malignancy|Trousseau sign]], in which blood clots form spontaneously in the [[portal venous system|portal blood vessels]], the deep veins of the extremities, or the superficial veins anywhere on the body, is sometimes associated with pancreatic cancer. [[Clinical depression]] has been reported in association with pancreatic cancer, sometimes presenting before the cancer is diagnosed. However, the mechanism for this association is not known.<ref>Carney CP, Jones L, Woolson RF, Noyes R Jr, Doebbeling BN. Relationship between depression and pancreatic cancer in the general population. ''Psychosom Med'' 2003;65:884-8. PMID 14508036.</ref> ===Predisposing factors=== Risk factors for pancreatic cancer include:<ref name="titleACS :: What Are the Risk Factors for Cancer of the Pancreas?">{{cite web |url=http://www.cancer.org/docroot/CRI/content/CRI_2_4_2X_What_are_the_risk_factors_for_pancreatic_cancer_34.asp?sitearea= |title=ACS :: What Are the Risk Factors for Cancer of the Pancreas? |accessdate=2007-12-13 |format= |work=}}</ref> *Age *Male gender *African-American ethnicity<ref name="NCI">{{cite web |url=http://www.cancer.gov/cancertopics/wyntk/pancreas/page4 |title=What You Need To Know About Cancer of the Pancreas - National Cancer Institute |accessdate=2007-12-22 |format= |work=}}</ref> *[[Tobacco smoking|Smoking]]. Cigarette smoking nearly doubles one's risk, and the risk persists for at least a decade after quitting. <ref>{{cite journal |journal= Langenbecks Arch Surg |date=2008 |title= Tobacco and the risk of pancreatic cancer: a review and meta-analysis |author= Iodice S, Gandini S, Maisonneuve P, Lowenfels AB |doi=10.1007/s00423-007-0266-2 |pmid=18193270 |volume= 393 |pages= 535}}</ref> *Diets high in red meat<ref>{{cite web |url=http://www.medscape.com/viewarticle/514268 |title=Red Meat May Be Linked to Pancreatic Cancer |accessdate=2008-03-05 |date=2005-10-05 |work=Journal of the National Cancer Institute |publisher=WebMD}}</ref> *[[Obesity]]<ref>{{cite web |url=http://www.cancer.org/docroot/NWS/content/NWS_1_1x_Obesity_Linked_to_Pancreatic_Cancer.asp |title=Obesity Linked to Pancreatic Cancer |accessdate=2008-03-05 |date=2005-03-06 |work=American Cancer Society |publisher=Cancer Epidemiology, Biomarkers & Prevention (Vol. 14, No. 2: 459-466)}}</ref> *[[Diabetes mellitus]] *[[Chronic pancreatitis]] has been linked, but is not known to be causal *''[[Helicobacter pylori]]'' infection *Occupational exposure to certain [[pesticide]]s, [[dye]]s, and chemicals related to [[gasoline]]{{Fact|date=March 2008}} *Family history, 5-10% of pancreatic cancer patients have a family history of pancreatic cancer. The genes responsible for most of this clustering in families have yet to be identified. Pancreatic cancer has been associated with the following syndromes; [[autosomal recessive]] [[ataxia-telangiectasia]] and autosomal dominantly inherited mutations in the [[BRCA2]] [[gene]], [[Peutz-Jeghers syndrome]] due to mutations in the STK11 tumor suppressor gene, [[hereditary non-polyposis colon cancer]] (Lynch syndrome), familial adenomatous polyposis, and the [[familial atypical multiple mole melanoma-pancreatic cancer syndrome]] (FAMMM-PC) due to mutations in the ''[[CDKN2A]]'' tumor suppressor gene.<ref>{{cite journal |author=Efthimiou E, Crnogorac-Jurcevic T, Lemoine NR, Brentnall TA |year=2001 |month=Feb |title=Inherited predisposition to pancreatic cancer |journal=Gut |volume=48 |issue=2 |pages=143–7 |pmid=11156628 |url= |doi=10.1136/gut.48.2.143}}</ref><ref name=Ghaneh/> *Gingivitis or periodontal disease.<ref>{{cite journal |author=Michaud DS, Joshipura K, Giovannucci E, Fuchs CS |title=A prospective study of periodontal disease and pancreatic cancer in US male health professionals |journal=J. Natl. Cancer Inst. |volume=99 |issue=2 |pages=171–5 |year=2007 |pmid=17228001 |doi=10.1093/jnci/djk021}}</ref> ==Diagnosis== History — Most patients with pancreatic cancer experience pain, weight loss, or [[jaundice]].<ref name="pmid1589710">{{cite journal |author=Bakkevold KE, Arnesjø B, Kambestad B |title=Carcinoma of the pancreas and papilla of Vater: presenting symptoms, signs, and diagnosis related to stage and tumour site. A prospective multicentre trial in 472 patients. Norwegian Pancreatic Cancer Trial |journal=Scand. J. Gastroenterol. |volume=27 |issue=4 |pages=317–25 |year=1992 |pmid=1589710|doi=10.3109/00365529209000081 }}</ref> Pain is present in 80 to 85 percent of patients with locally advanced or advanced metastic disease. The pain is usually felt in the upper abdomen as a dull ache that radiates straight through to the back. It may be intermittent and made worse by eating. Weight loss can be profound; it may be associated with [[anorexia]], early [[satiety]], diarrhea, or [[steatorrhea]]. [[Jaundice]] is often accompanied by [[Itch|pruritus]] and dark urine. Painful jaundice is present in approximately one-half of patients with locally unresectable disease, while painless jaundice is present in approximately one-half of patients with a potentially resectable and curable lesion. The initial presentation varies according to tumor location. Tumors in the pancreatic body or tail usually present with pain and weight loss, while those in the head of the gland typically present with steatorrhea, weight loss, and jaundice. The recent onset of atypical diabetes mellitus, a history of recent but unexplained [[thrombophlebitis]]([[Trousseau's sign]]), or a previous attack of [[pancreatitis]] are sometimes noted. [[Courvoisier's law|Courvoisier sign]] defines the presence of jaundice and a painlessly distended [[gallbladder]] as strongly indicative of pancreatic cancer, and may be used to distinguish pancreatic cancer from [[gallstone]]s. Pancreatic cancer is usually discovered during the course of the evaluation of aforementioned symptoms. [[Liver function test]]s may show a combination of results indicative of bile duct obstruction (raised [[conjugated bilirubin]], [[Gamma glutamyl transpeptidase|γ-glutamyl transpeptidase]] and [[alkaline phosphatase]] levels). [[CA19-9]] (carbohydrate antigen 19.9) is a [[tumor marker]] that is frequently elevated in pancreatic cancer. However, it lacks sensitivity and specificity. When a cutoff above 37 U/mL is used, this marker has a sensitivity of 77% and specificity of 87% in discerning benign from malignant disease. CA 19-9 may be normal early in the course, and may be elevated due to benign causes of biliary obstruction.<ref>{{cite book |author=Frank J. Domino M.D.etc. |title=5 minutes clinical suite version 3 | year=2007 | publisher=Lippincott Williams & Wilkins | location=Philadelphia, PA}}</ref> Imaging studies, such as [[medical ultrasonography|ultrasound]] or abdominal [[Computed tomography|CT]] may be used to identify tumors. [[Endoscopic ultrasound]] (EUS) is another procedure that can help visualize the tumor and obtain tissue to establish the diagnosis. Endoscopic retrograde cholangiopancreatography (ERCP) is also used. ==Treatment== ===Surgery=== Treatment of pancreatic cancer depends on the stage of the cancer.<ref>[http://pathology.jhu.edu/pancreas/TreatmentSurgery.php]</ref> The [[Whipple procedure]] is the most common surgical treatment for cancers involving the head of the pancreas. It can only be performed if the patient is likely to survive major surgery, and if the tumor is localised without invading local structures or metastasizing. It can therefore only be performed in the minority of cases. Recent advances have made possible resection (surgical removal) of tumors that were previously unresectable due to blood vessel involvement.{{Fact|date=April 2008}} Tumors of the tail of the pancreas can be resected using a procedure known as a distal pancreatectomy [http://pathology.jhu.edu/pancreas/TreatmentSurgery.php], and recently localized tumors of the pancreas have been resected using minimally invasive (laproscopic) approaches. After surgery, ''adjuvant'' chemotherapy with [[gemcitabine]] may be offered to eliminate whatever tumor tissue may remain in the body. This has been shown to increase 5-year survival rates. Addition of [[radiation therapy]] is a hotly debated topic, with groups in the US often favoring the use of adjuvant radiation therapy, while groups in Europe do not.<ref name="pmid15028824">{{cite journal |author=Neoptolemos JP, Stocken DD, Friess H, ''et al'' |title=A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer |journal=N. Engl. J. Med. |volume=350 |issue=12 |pages=1200–10 |year=2004 |pmid=15028824 |doi=10.1056/NEJMoa032295}}</ref> Surgery may be performed for palliation, if the tumor is invading or compressing the [[duodenum]] or [[colon (anatomy)|colon]]. In that case, bypass surgery may overcome the obstruction and improve quality of life, but it is not intended as a cure. ===Chemotherapy=== In patients not suitable for resection with curative intent, palliative [[chemotherapy]] may be used to improve quality of life and gain a modest survival benefit. [[Gemcitabine]] was approved by the US [[FDA]] in 1998 after a clinical trial reported improvements in [[quality of life]] in patients with advanced pancreatic cancer. This marked the first FDA approval of a chemotherapy drug for a non-survival [[clinical trial]] endpoint. Gemcitabine is administered intravenously on a weekly basis. Addition of [[oxaliplatin]] (Gem/Ox) conferred benefit in small trials, but is not yet standard therapy.<ref name="pmid16434988">{{cite journal |author=Demols A, Peeters M, Polus M, ''et al'' |title=Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study |journal=Br. J. Cancer |volume=94 |issue=4 |pages=481–5 |year=2006 |pmid=16434988 |doi=10.1038/sj.bjc.6602966}}</ref> [[Fluorouracil]] (5FU) may also be included. On the basis of a Canadian led Phase III Randomised Controlled trial involving 569 patients with advanced pancreatic cancer, the US FDA has licensed the use of [[erlotinib]] (Tarceva) in combination with [[gemcitabine]] as a palliative regimen for pancreatic cancer. This trial compared the action of gemcitabine/erlotinib vs gemcitabine/placebo and demonstrated improved survival rates, improved tumor response and improved progression-free survival rates. The survival improvement with the combination is on the order of less than four weeks, leading some [[cancer]] experts to question the incremental value of adding [[erlotinib]] to [[gemcitabine]] treatment. New trials are now investigating the effect of the above combination in the adjuvant and neoadjuvant setting.<ref>[http://www.fda.gov/ohrms/dockets/AC/05/briefing/2005-4174B1_03_01-OSI-Tarceva.pdf#search=%22%20fda%20erlotinib%20pancreatic%22 FDA approval briefing]</ref> A trial of anti-angiogenesis agent [[bevacizumab]] (Avastin) as an addition to chemotherapy has shown no improvement in survival of patients with advanced pancreatic cancer. It may cause higher rates of high blood pressure, bleeding in the stomach and intestine, and intestinal perforations. ==Prognosis== Patients diagnosed with pancreatic cancer typically have a poor [[prognosis]] partly because the cancer usually causes no symptoms early on, leading to locally advanced or [[metastatic]] disease at time of diagnosis. Median survival from diagnosis is around 3 to 6 months; 5-year survival is less than 5%.<ref>[http://www.who.int/tobacco/research/cancer/en/ WHO | Cancer<!-- Bot generated title -->]</ref> With 37,170 cases diagnosed in the United States in 2007, and 33,700 deaths, pancreatic cancer has one of the highest fatality rates of all cancers and is the fourth highest cancer killer in the United States among both men and women. Although it accounts for only 2.5% of new cases, pancreatic cancer is responsible for 6% of cancer deaths each year.<ref>[http://caonline.amcancersoc.org/cgi/content/full/57/1/43 Cancer Statistics, 2007 - Jemal et al. 57 (1): 43 - CA: A Cancer Journal for Clinicians<!-- Bot generated title -->]</ref> Pancreatic cancer may occasionally result in [[Diabetes mellitus|diabetes]]. Insulin production is hampered and it has been suggested that the cancer can also prompt the onset of diabetes and vice versa.<ref>[http://www.molecular-cancer.com/content/2/1/4 Molecular Cancer | Full text | The relationship between diabetes and pancreatic cancer<!-- Bot generated title -->]</ref> Thus diabetes is both a risk factor for the development of pancreatic cancer and diabetes can be an early sign of the disease in the elderly. ==Prevention== According to the [[American Cancer Society]], there are no established guidelines for preventing pancreatic cancer, although [[Tobacco smoking|cigarette smoking]] is responsible for 20-30% of pancreatic cancers.<ref name="titleACS :: Can Cancer of the Pancreas be Prevented?">{{cite web |url=http://www.cancer.org/docroot/CRI/content/CRI_2_4_2X_Can_pancreatic_cancer_be_prevented_34.asp?rnav=cri |title=ACS :: Can Cancer of the Pancreas be Prevented? |accessdate=2007-12-13 |format= |work=}}</ref> The ACS recommends keeping a healthy weight, and increasing consumption of fruits, vegetables, and whole grains while decreasing red meat intake, although there is no consistent evidence that this will prevent or reduce pancratic cancer specifically.<ref> {{cite journal|title=Predictors of pancreatic cancer mortality among a large cohort of United States adults|journal=Cancer Causes Control. |date=2000 Dec|first=SS|last=Coughlin |coauthors=Calle EE, Patel AV, Thun MJ.|volume=11|issue=10|pages=915–23.|pmid=11142526 |url=|format=|accessdate=2007-02-27|doi=10.1023/A:1026580131793}}</ref><ref> {{cite journal|title=A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States)|journal=Cancer Causes Control. |date=1993 Sep|first=W|last=Zheng |coauthors=et al|volume=4|issue=5|pages=477–82. |pmid=8218880 |url=|format=|accessdate=2007-02-27|doi=10.1007/BF00050867}}</ref> In 2006 a large prospective cohort study of over 80,000 subjects failed to prove a definite association.<ref> {{cite journal|title=Fruit and vegetable consumption in relation to pancreatic cancer risk: a prospective study|journal=Cancer Epidemiology Biomarkers & Prevention|date=February 2006|first=Susanna|last=Larsson|coauthors=Niclas Håkansson, Ingmar Näslund, Leif Bergkvist and Alicja Wolk|volume=15|issue=|pages=301–305|pmid=16492919 |url=|format=|accessdate=2007-02-27|doi=10.1158/1055-9965.EPI-05-0696}}</ref> The evidence in support of this lies mostly in small case-control studies. In September 2006, a long-term study concluded that taking [[Vitamin D]] can substantially cut the risk of pancreatic cancer (as well as other cancers) by up to 50%.<ref>[http://news.bbc.co.uk/1/hi/health/5334534.stm BBC NEWS | Health | Vitamin D 'slashes cancer risk'<!-- Bot generated title -->]</ref><ref>[http://www.webmd.com/content/article/127/116673.htm Vitamin D May Cut Pancreatic Cancer<!-- Bot generated title -->]</ref><ref>http://www.forbes.com/forbeslife/health/feeds/hscout/2006/09/14/hscout534925.html</ref> More studies of this have been called for. Several studies, including one published June 1, 2007, indicate that [[B vitamins]] such as [[B12]], [[Vitamin B6|B6]], and [[folate]], can reduce the risk of pancreatic cancer when consumed in food, but not when ingested in vitamin tablet form.<ref>{{cite web |url=http://cancerres.aacrjournals.org/cgi/content/abstract/67/11/5553 |title=Plasma Folate, Vitamin B6, Vitamin B12, and Homocysteine and Pancreatic Cancer Risk in Four Large Cohorts -- Schernhammer et al. 67 (11): 5553 -- Cancer Research |accessdate=2007-06-04 |format= |work=}}</ref><ref>{{cite web |url=http://www.upi.com/Consumer_Health_Daily/Briefing/2007/06/01/pancreatic_cancer_risk_cut_by_b6_b12/3712/ |title=United Press International - Consumer Health Daily - Briefing |accessdate=2007-06-04 |format= |work=}}</ref> It would be, however, premature at this point in time to consume vitamins specifically with the hope of preventing pancreatic cancer. ==Awareness== <!-- Deleted image removed: [[Image:PanCAN Ribbon.gif|right]] --> *November is Pancreatic Cancer [[Awareness ribbon|Awareness]] Month *Purple is the traditional color chosen to represent pancreatic cancer awareness. *The National Cancer Institute’s cancer research budget was $4.824 billion in 2004, an estimated $52.7 million of which was devoted to pancreatic cancer.<ref>[http://pancan.org/About/pancreaticCancerStats.html PanCAN - Working Together for a Cure™<!-- Bot generated title -->]</ref> *Research spending per pancreatic cancer patient is $1145, the lowest of any leading cancer.<ref>[http://pancan.org/About/pancreaticCancerStats.html PanCAN - Working Together for a Cure™<!-- Bot generated title -->]</ref> *For a list of celebrities who have succumbed to this disease, see [[:Category:Pancreatic cancer deaths]]. For a list of survivors see [[:Category:Pancreatic cancer survivors]]. *The Pancreatic Cancer Action Network ([[PanCAN]]) was created as an advocacy group for pancreatic cancer. ==References== {{reflist|2}} ==External links== * [http://pathology.jhu.edu/pancreas/ The Johns Hopkins Pancreatic Cancer Web Site] * [http://www.pancan.org/ Pancreatic Cancer Action Network (PanCAN)] * [http://www.pancsoc.org.uk/ The Pancreatic Society of Great Britain and Ireland] * [http://pathology.jhu.edu/pancreas/PANCREAS_CHAT The Johns Hopkins Pancreatic Cancer Web Site Discussion Board] * [http://survivor-support.rare-cancer.org/forum/ Rare Pancreatic & Neuroendocrine Cancer Support] * [http://www.pancreaticcancer.org.uk Pancreatic Cancer UK] * [http://www.pancreatica.org/ Confronting Pancreatic Cancer] (Pancreatica.org) * [http://www.cancersupportivecare.com/pancreas.html Cancer of the Pancreas] (Cancer Supportive Care Program) * [http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?rnav=cridg&dt=34 American Cancer Society: Detailed Guide on Pancreatic Cancer] * [http://pathology2.jhu.edu/pancreas/nfptr.cfm The National Familial Pancreas Tumor Registry] * [http://www.pccrproject.com/ Pancreatic Cancer Collaborative Registry (PCCR)] * [http://www.lustgarten.org/LUS/CDA/HomePage.jsp The Lustgarten Foundation For Pancreatic Cancer Research] {{Gastroenterology}} {{Digestive system neoplasia}} [[Category:Types of cancer]] [[ar:ورم البنكرياس]] [[bs:Rak gušterače]] [[da:Pancreascancer]] [[de:Pankreastumor]] [[es:Cáncer de páncreas]] [[eo:Pankreata karcinomo]] [[fr:Cancer du pancréas]] [[ko:췌장암]] [[it:Cancro del pancreas]] [[he:סרטן הלבלב]] [[la:Cancer pancreaticus]] [[lt:Kasos vėžys]] [[nl:Alvleesklierkanker]] [[ja:膵癌]] [[no:Bukspyttkjertelkreft]] [[pl:Rak trzustki]] [[pt:Câncer pancreático]] [[fi:Haimasyöpä]] [[sv:Pankreascancer]] [[tr:Pankreas kanseri]] [[zh:胰腺癌]]